CD163 immunohistochemistry is superior to CD68 in predicting outcome in classical Hodgkin lymphoma. (Q53095335)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CD163 immunohistochemistry is superior to CD68 in predicting outcome in classical Hodgkin lymphoma. |
scientific article |
Statements
CD163 immunohistochemistry is superior to CD68 in predicting outcome in classical Hodgkin lymphoma (English)
Jonathan L Klein
TuDung T Nguyen
Gabriel A Bien-Willner
Ling Chen
Kelley V Foyil
Eric J Duncavage
Anjum Hassan
John L Frater
Friederike Kreisel